amdinocillin has been researched along with aztreonam in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanberger, H | 1 |
| Nemoto, M; Saitoh, K; Sakurai, Y; Sawai, T; Yamaguchi, A; Yoshida, Y | 1 |
| Hanberger, H; Maller, R; Nilsson, LE; Nilsson, M | 1 |
| Canepari, P; Cornaglia, G; Pompei, R; Satta, G | 1 |
| Barriere, SL | 1 |
| Boaretti, M; Canepari, P; Lleò, MM; Signoretto, C | 1 |
| Cars, O; Cars, T; Hickman, RA; Hughes, D; Malmberg, C | 1 |
| Carlson, EE; Kocaoglu, O | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
1 review(s) available for amdinocillin and aztreonam
| Article | Year |
|---|---|
Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Kinetics | 1986 |
11 other study(ies) available for amdinocillin and aztreonam
| Article | Year |
|---|---|
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin | 1992 |
Characteristics of aztreonam as a substrate, inhibitor and inducer for beta-lactamases.
Topics: Amdinocillin; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Cephalosporins; Citrobacter; Drug Synergism; Enzyme Induction; Escherichia coli; Gram-Negative Bacteria; Hydrolysis; Penicillinase; Proteus vulgaris; Pseudomonas aeruginosa | 1990 |
Pharmacodynamics of beta-lactam antibiotics on gram-negative bacteria: initial killing, morphology and postantibiotic effect.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Spheroplasts | 1990 |
Evaluation of bactericidal activity of cefotaxime and other beta-lactams by a novel method.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cefsulodin; Dose-Response Relationship, Drug; Escherichia coli; Hexosyltransferases; Kinetics; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Time Factors | 1988 |
Cell elongation and septation are two mutually exclusive processes in Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Cell Cycle; Cell Wall; Escherichia coli; Monobactams; Morphogenesis; Peptidoglycan; Time Factors | 1997 |
Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; Cell Wall; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; Fosfomycin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2014 |
Profiling of β-lactam selectivity for penicillin-binding proteins in Escherichia coli strain DC2.
Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefotaxime; Cefuroxime; Escherichia coli; Microbial Sensitivity Tests; Penicillin-Binding Proteins | 2015 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |